Status:
RECRUITING
Investigation of Cerebral Motor Activity Modulations Following Median Nerve Stimulation During General Anaesthesia
Lead Sponsor:
Brugmann University Hospital
Conditions:
Accidental Awareness During General Anesthesia
Eligibility:
MALE
18-81 years
Phase:
EARLY_PHASE1
Brief Summary
Accidental Awareness during General Anesthesia (AAGA) occurs in 1-2% of high-risk practice patients and is a cause of severe psychological trauma, termed post-traumatic stress disorder (PTSD). Actuall...
Eligibility Criteria
Inclusion
- Patients \>18 years and \<81 years
- Right-handed
- Programmed for surgery with the use of an intravenous anesthesia with a propofol concentration objective
Exclusion
- Allergy to propofol, soy or peanuts
- BMI\<20 or \>30
- Pregnant or breastfeeding women
- Adult unable to give consent
- Medical or surgical history that may interfere with median nerve stimulation or the obtention of the EEG signal (for example: diabetes, polyneuropathy, central neurodegenerative disease, epilepsy, brain surgery)
- History of right median nerve injury
- Amputation of the upper right limb
- Impossibility of affixing an EEG helmet
- Addiction
Key Trial Info
Start Date :
January 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05272202
Start Date
January 15 2023
End Date
December 31 2026
Last Update
February 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020